scholarly journals Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge † †Coupling Muscle and Nerve 2009—XI. International Expert Meeting on Neuromuscular Physiology and Pharmacology, June 17, 2009, Munich, Germany. Abstract published in Br J Anaesth 2009; 103: 911–2.

2010 ◽  
Vol 105 (3) ◽  
pp. 304-309 ◽  
Author(s):  
A Butterly ◽  
E.A. Bittner ◽  
E George ◽  
W.S. Sandberg ◽  
M Eikermann ◽  
...  
Keyword(s):  
Recovery Room ◽  
Neuromuscular Blocking ◽  
Neuromuscular Blocking Agents ◽  
International Expert ◽  
Blocking Agents ◽  
Expert Meeting ◽  
Residual Curarization ◽  
Postoperative Residual

scholarly journals Dosing of neuromuscular blocking agents in patients with obesity: A narrative review

2021 ◽  
pp. 0310057X2096857
Author(s):  
Brian L Erstad ◽  
Jeffrey F Barletta
Keyword(s):  
Body Weight ◽  
Ideal Body Weight ◽  
Neuromuscular Blocking ◽  
Neuromuscular Blocking Agents ◽  
Patient Specific ◽  
Lean Body Weight ◽  
Short Term ◽  
Blocking Agents ◽  
Ideal Body ◽  
Size Descriptor

There is no consensus on which weight clinicians should use for weight-based dosing of neuromuscular blocking agents (NMBAs), as exemplified by differing or absent recommendations in clinical practice guidelines. The purpose of this paper is to review studies that evaluated various size descriptors for weight-based dosing of succinylcholine and non-depolarising NMBAs, and to provide recommendations for the descriptors of choice for the weight-based dosing of these agents in patients with obesity. All of the studies conducted to date involving depolarising and non-depolarising NMBAs in patients with obesity have assessed single doses or short-term infusions conducted in perioperative settings. Recognising that any final dosing regimen must take into account patient-specific considerations, the available evidence suggests that actual body weight is the size descriptor of choice for weight-based dosing of succinylcholine and that ideal body weight, or an adjusted (or lean) body weight, is the size descriptor of choice for weight-based dosing of non-depolarising NMBAs.

Fumarates: Unique nondepolarizing neuromuscular blocking agents that are antagonized by cysteine

2009 ◽  
Vol 24 (1) ◽  
pp. 50-57 ◽  
Author(s):  
Cynthia A. Lien ◽  
Peter Savard ◽  
Matthew Belmont ◽  
Hiorshi Sunaga ◽  
John J. Savarese
Keyword(s):  
Neuromuscular Blocking ◽  
Neuromuscular Blocking Agents ◽  
Blocking Agents
Sign in / Sign up

Export Citation Format

Share Document